Missed recovery dates
As of Sep 30, 2026, 21 FDA-listed shortage presentations are past the recovery date their manufacturer gave the FDA.
The FDA's drug-shortages record includes a manufacturer's own "estimated recovery" note for many presentations. When that date passes without the shortage resolving, the note stays up — so this page surfaces the ones that have slipped. It is a derived view of public openFDA data, not an FDA statement.
| Medication | Manufacturer | NDC | Stated recovery | Overdue |
|---|---|---|---|---|
| Metronidazole Injection | InfoRLife SA | 25021-131-82 | August 2026 | 61 days |
| Dextrose Monohydrate 70% Injection | Baxter Healthcare | 0338-0719-06 | September 2026 | 30 days |
| Carboplatin Injection | Hospira, Inc., a Pfizer Company | 61703-339-56 | September 2026 | 30 days |
| Sodium Acetate Injection | Hospira, Inc., a Pfizer Company | 0409-3299-06 | September 2026 | 30 days |
| Atropine Sulfate Injection | Hospira, Inc., a Pfizer Company | 0409-1630-10 | September 2026 | 30 days |
| Ifosfamide Injection | Baxter Healthcare | 0338-3991-01 | September 2026 | 30 days |
| Methylphenidate Hydrochloride Tablet, Extended Release | Teva Pharmaceuticals USA, Inc. | 62037-725-01 | September 2026 | 30 days |
| Atropine Sulfate Injection | Accord Healthcare Inc. | 16729-525-08 | mid-September 2026 | 30 days |
| Methylphenidate Hydrochloride Tablet, Extended Release | Teva Pharmaceuticals USA, Inc. | 62037-726-01 | September 2026 | 30 days |
| Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | 0409-2308-02 | September 2026 | 30 days |
| Dexmedetomidine Hydrochloride Injection | Baxter Healthcare | 0338-9555-24 | September 2026 | 30 days |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | 0555-0777-02 | September 2026 | 30 days |
| Sterile Water Irrigant | Baxter Healthcare | 0338-0004-04 | September 2026 | 30 days |
| Midazolam Hydrochloride Injection | Avet Pharmaceuticals, Inc. | 23155-600-41 | 9/25/2026 | 6 days |
| Lidocaine Hydrochloride Injection | Eugia US LLC | 55150-252-20 | late September 2026 | 3 days |
| Lidocaine Hydrochloride Injection | Eugia US LLC | 55150-255-20 | late September 2026 | 3 days |
| Ketorolac Tromethamine Injection | Sagent Pharmaceuticals | 25021-700-01 | late September 2026, Product in transit | 3 days |
| Methotrexate Sodium Injection | Accord Healthcare Inc. | 16729-277-30 | late September 2026 | 3 days |
| Bumetanide Injection | Sagent Pharmaceuticals | 25021-321-04 | late September 2026 | 3 days |
| Lidocaine Hydrochloride Injection | Eugia US LLC | 55150-165-05 | late September 2026 | 3 days |
| Technetium TC-99M Pyrophosphate Kit Injection | Curium US LLC | 69945-094-20 | late September 2026 | 3 days |
"Overdue" is measured from the first of the stated month (or the exact date when one is given). A note like "September 2026" is counted as overdue once October 1 arrives. Sign up on any drug page for a change-only alert when its record updates.
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).